Scinai Immunotherapeutics Ltd - ADR

Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer.
Quotes
- Bid
- Ask
- Open
- Previous close
- Volume
- Relative volume
- High
- Low
Returns
Key stats
ESG risk
ESG risk is a measure of how well a company manages material ESG risks. Sustainalytics’ ESG risk category is designed to help investors identify and understand financially material ESG risks at the company level and how they might affect the long-term performance for equity investments. The scale is from 0-100. The lower the risk, the better (0 is equivalent to no risk and 100 the most severe).
Download ESG risk methodology (PDF)Financials
About Scinai Immunotherapeutics Ltd - ADR
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai’s drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.
Frequently asked questions
You need to open and fund a Saxo account to buy Scinai Immunotherapeutics Ltd - ADR stock. Once the account is approved, you can login to the platform (SaxoInvestor or SaxoTrader), search for Scinai Immunotherapeutics Ltd - ADR (by name) or ‘APPL’ (by ticker), choose the number of shares you wish to buy, and place your order.
The ticker symbol for Scinai Immunotherapeutics Ltd - ADR is SCNI_NEW:xnas. You can use this code to find the stock in our platforms and track its price and performance.
Scinai Immunotherapeutics Ltd - ADR has its primary listing on NASDAQ (Small cap). You can trade Scinai Immunotherapeutics Ltd - ADR with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Scinai Immunotherapeutics Ltd - ADR is available to trade on SaxoInvestor and SaxoTrader. You can buy Scinai Immunotherapeutics Ltd - ADR stock directly and include it as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Scinai Immunotherapeutics Ltd - ADR or others.